Veronique Scott
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.
Journal: Cancer discovery
Published: August 31, 2022
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.
Journal: NAR cancer
Published: July 08, 2020
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.
Journal: JCO precision oncology
Published: October 03, 2019
Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing.
Journal: Cancer research
Published: August 01, 2019
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.
Journal: Breast cancer research and treatment
Published: August 04, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 13, 2018
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 14, 2017
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Journal: PLoS medicine
Published: October 04, 2016
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: June 13, 2016
Whole exome sequencing of rare aggressive breast cancer histologies.
Journal: Breast cancer research and treatment
Published: October 09, 2015
Last Updated: 09/26/2026